Vitamin K-dependent coagulation factors deficiency

Seminars in Thrombosis and Hemostasis

Volumn 35, Issue 4, 2009, Pages 439-446

  Brenner, Benjamin ^a   Kuperman, Amir A ^a   Watzka, Matthias ^b   Oldenburg, Johannes ^b  

^a RAMBAM MEDICAL CENTER   (Israel)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

glutamyl carboxylase (GGCX); Vitamin K epoxide reductase (VKOR); Vitamin K dependent coagulation factors deficiency (VKCFD)

Indexed keywords

FRESH FROZEN PLASMA; MENADIONE EPOXIDE; PROTEIN VKORC 1; PROTHROMBIN COMPLEX; UNCLASSIFIED DRUG; VITAMIN K DEPENDENT CARBOXYLASE; VITAMIN K GROUP;

BLEEDING; BLOOD CLOTTING DISORDER; CLINICAL FEATURE; ENZYME RELEASE; GENE MUTATION; HUMAN; LABORATORY TEST; PHENOTYPE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; VITAMIN K DEFICIENCY; VITAMIN K DEPENDENT COAGULATION FACTOR DEFICIENCY;

BLOOD COAGULATION FACTORS; CARBON-CARBON LIGASES; CHILD; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MIXED FUNCTION OXYGENASES; PARTIAL THROMBOPLASTIN TIME; PHENOTYPE; PRENATAL DIAGNOSIS; PREOPERATIVE CARE; PROTHROMBIN TIME; VITAMIN K; VITAMIN K DEFICIENCY;

EID: 67749142062     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0029-1225766     Document Type: Review

References (61)

1. Furie B, Bouchard BA, Furie BC. Vitamin K-dependent biosynthesis of gamma-carboxyglutamic acid. Blood 1999;93: 1798-1808 (Pubitemid 29128479)
2. McMillan CW, Roberts HR. Congenital combined deficiency of coagulation factors II, VII, IX and X. Report of a case. N Engl J Med 1966;274:1313-1315
3. Fischer M, Zweymuller E. Kongenitaler Mangel der faktoren II, VII und X. Zeitschrift fuer kinderheikunde 1966;95:309-323
4. Johnson CA, Chung KS, McGrath KM, Bean PE, Roberts HR. Characterization of a variant prothrombin in a patient congenitally deficient in factors II, VII, IX and X. Br J Haematol 1980;44:461-469
5. Mickleson KN, Whyte G. Severe deficiency of vitamin K dependent coagulation factors in an infant. N Z Med J 1979;90:291-292 (Pubitemid 10144578)
6. Thomas A, Stirling D. Four factor deficiency. Blood Coagul Fibrinolysis 2003;14(Suppl 1):S55-S57
7. Puetz J, Knutsen A, Bouhasin J. Congenital deficiency of vitamin K-dependent coagulation factors associated with central nervous system anomalies. Thromb Haemost 2004; 91:819-821 (Pubitemid 38477465)
8. Goldsmith GH Jr, Pence RE, Ratnoff OD, Adelstein DJ, Furie B. Studies on a family with combined functional deficiencies of vitamin K-dependent coagulation factors. J Clin Invest 1982;69:1253-1260
9. Vicente V, Maia R, Alberca I, Tamagnini GPT, Lopez Borrasca A. Congenital deficiency of vitamin K-dependent coagulation factors and protein C. Thromb Haemost 1984; 51:343-346 (Pubitemid 14097888)
10. Ekelund H, Lindeberg L, Wranne L. Combined deficiency of coagulation factors II, VII, IX, and X: a case of probable congenital origin. Pediatr Hematol Oncol 1986;3:187-193
11. Pauli RM, Lian JB, Mosher DF, Suttie JW. Association of congenital deficiency of multiple vitamin K-dependent coagulation factors and the phenotype of the warfarin embryopathy: clues to the mechanism of teratogenicity of coumarin derivatives. Am J Hum Genet 1987;41:566-583
12. Leonar CO. Vitamin K responsive bleeding disorder: a genocopy of the warfarin embryopathy. Proceeding of the Greenwood Genetic Center 1988;7:165-166
13. Pechlaner C, Vogel W, Erhart R, Pümpel E, Kunz F. A new case of combined deficiency of vitamin K dependent coagulation factors. Thromb Haemost 1992;68:617
14. Ghosh K, Shetty S, Mohanty D. Inherited deficiency of multiple vitamin K-dependent coagulation factors and coagulation inhibitors presenting as hemorrhagic diathesis, mental retardation, and growth retardation. Am J Hematol 1996;52: 67 (Pubitemid 26140050)
15. Boneh A, Bar-Ziv J. Hereditary deficiency of vitamin K-dependent coagulation factors with skeletal abnormalities. Am J Med Genet 1996;65:241-243 (Pubitemid 26374801)
16. Brenner B, Sánchez-Vega B, Wu SM, Lanir N, Stafford DW, Solera J. A missense mutation in gamma-glutamyl carboxylase gene causes combined deficiency of all vitamin K-dependent blood coagulation factors. Blood 1998;92: 4554-4559 (Pubitemid 29005856)
17. Spronk HM, Farah RA, Buchanan GR, Vermeer C, Soute BA. Novel mutation in the gamma-glutamyl carboxylase gene resulting in congenital combined deficiency of all vitamin K-dependent blood coagulation factors. Blood 2000;96:3650-3652 (Pubitemid 30836351)
18. Oldenburg J, von Brederlow B, Fregin A, et al. Congenital deficiency of vitamin K dependent coagulation factors in two families presents as a genetic defect of the vitamin K-epoxide-reductase-complex. Thromb Haemost 2000;84:937-941 (Pubitemid 32014026)
19. Rost S, Fregin A, Koch D, Compes M, Müller CR, Oldenburg J. Compound heterozygous mutations in the gamma-glutamyl carboxylase gene cause combined deficiency of all vitamin K-dependent blood coagulation factors. Br J Haematol 2004;126:546-549 (Pubitemid 39093097)
20. Bhattacharyya J, Dutta P, Mishra P, et al. Congenital vitamin K-dependent coagulation factor deficiency: a case report. Blood Coagul Fibrinolysis 2005;16:525-527 (Pubitemid 41794948)
21. Darghouth D, Hallgren KW, Shtofman RL, et al. Compound heterozygosity of novel missense mutations in the gamma-glutamyl-carboxylase gene causes hereditary combined vitamin K-dependent coagulation factor deficiency. Blood 2006;108:1925-1931 (Pubitemid 44395002)
22. Marchetti G, Caruso P, Lunghi B, et al. Vitamin K-induced modification of coagulation phenotype in VKORC1 homozygous deficiency. J Thromb Haemost 2008;6:797-803
23. Kuo WL, Stafford DW, Cruces J, Gray J, Solera J. Chromosomal localization of the gamma-glutamyl carboxylase gene at 2p12. Genomics 1995;25:746-748
24. Fregin A, Rost S, Wolz W, Krebsova A, Muller CR, Oldenburg J. Homozygosity mapping of a second gene locus for hereditary combined deficiency of vitamin K-dependent clotting factors to the centromeric region of chromosome 16. Blood 2002;100:3229-3232 (Pubitemid 35217071)
25. Rost S, Fregin A, Ivaskevicius V, et al. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature 2004;427:537-541 (Pubitemid 38209110)
26. Soute BAM, Ulrich MMW, Watson ADJ, Maddison JE, Ebberink RH, Vermeer C. Congenital deficiency of all vitamin K-dependent blood coagulation factors due to a defective vitamin K-dependent carboxylase in Devon Rex cats. Thromb Haemost 1992;68:521-525
27. Rieder MJ, Reiner AP, Gage BF, et al. Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose. N Engl J Med 2005;352:2285-2293
28. Yuan HY, Chen JJ, Lee MT, et al. A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity. Hum Mol Genet 2005;14:1745-1751
29. Schwarz UI, Ritchie MD, Bradford Y, et al. Genetic determinants of response to warfarin during initial anti-coagulation. N Engl J Med 2008;358:999-1008 (Pubitemid 351347099)
30. Zhu A, Sun H, Raymond RM Jr, et al. Fatal hemorrhage in mice lacking g-glutamyl carboxylase. Blood 2007;109:5270-5275 (Pubitemid 46890547)
31. Brenner B, Tavori S, Zivelin A, et al. Hereditary deficiency of all vitamin K-dependent procoagulants and anticoagulants. Br J Haematol 1990;75:537-542 (Pubitemid 20271485)
32. Menger H, Lin AE, Toriello HV, Bernert G, Spranger JW. Vitamin K deficiency embryopathy: a phenocopy of the warfarin embryopathy due to a disorder of embryonic vitamin K metabolism. Am J Med Genet 1997;72:129-134 (Pubitemid 27426076)
33. Vanakker OM, Martin L, Gheduzzi D, et al. Pseudox-anthoma elasticum-like phenotype with cutis laxa and multiple coagulation factor deficiency represents a separate genetic entity. J Invest Dermatol 2007;127:581-587 (Pubitemid 46271025)
34. Wu SM, Cheung WF, Frazier D, Stafford DW. Cloning and expression of the cDNA for human gamma-glutamyl carboxylase. Science 1991;254:1634-1636 (Pubitemid 21917505)
35. Wu SM, Stafford DW, Frazier LD, et al. Genomic sequence and transcription start site for the human gamma-glutamyl carboxylase. Blood 1997;89:4058-4062
36. Tie J, Wu SM, Jin D, Nicchitta CV, Stafford DW. A topological study of the human gamma-glutamyl carboxylase. Blood 2000;96:973-978 (Pubitemid 30616862)
37. Schmidt-Krey I, Haase W, Mutucumarana V, Stafford DW, Kühlbrandt W. Two-dimensional crystallization of human vitamin K-dependent γ-glutamyl carboxylase. J Struct Biol 2007;157:437-442 (Pubitemid 46109332)
38. Pan LC, Price PA. The propeptide of rat bone gamma-carboxyglutamic acid protein shares homology with other vitamin K-dependent protein precursors. Proc Natl Acad Sci U S A 1985;82:6109-6113
39. Knobloch JE, Suttie JW. Vitamin K-dependent carboxylase. Control of enzyme activity by the "propeptide" region of factor X. J Biol Chem 1987;262:15334-15337
40. Price PA, Williamson MK. Substrate recognition by the vitamin K-dependent gamma-glutamyl carboxylase: identification of a sequence homology between the carboxylase and the carboxylase recognition site in the substrate. Protein Sci 1993;2:1987-1988
41. Lin PJ, Jin DY, Tie JK, Presnell SR, Straight DL, Stafford DW. The putative vitamin K-dependent gamma-glutamyl carboxylase internal propeptide appears to be the propeptide binding site. J Biol Chem 2002;277:28584-28591
42. Mutucumarana VP, Acher F, Straight DL, Jin DY, Stafford DW. A conserved region of human vitamin K-dependent carboxylase between residues 393 and 404 is important for its interaction with the glutamate substrate. J Biol Chem 2003; 278:46488-46493 (Pubitemid 37452221)
43. Soute BA, Groenen-van Dooren MM, Holmgren A, Lundström J, Vermeer C. Stimulation of the dithioldependent reductases in the vitamin K cycle by the thioredoxin system. Strong synergistic effects with protein disulphide- isomerase. Biochem J 1992;281(Pt 1):255-259
44. Sugiura I, Furie B, Walsh CT, Furie BC. Propeptide and glutamate-containing substrates bound to the vitamin K-dependent carboxylase convert its vitamin K epoxidase function from an inactive to an active state. Proc Natl Acad Sci U S A 1997;94:9069-9074 (Pubitemid 27357783)
45. Bell RG, Matschiner JT. Vitamin K activity of phylloquinone oxide. Arch Biochem Biophys 1970;141:473-476
46. Kohn MH, Pelz HJ. Genomic assignment of the warfarin resistance locus, Rw, in the rat. Mamm Genome 1999;10: 696-698 (Pubitemid 29393675)
47. Wallace ME, MacSwiney FJ. A major gene controlling warfarin-resistance in the house mouse. J Hyg (Lond) 1976; 76:173-181
48. Li T, Chang CY, Jin DY, Lin PJ, Khvorova A, Stafford DW. Identification of the gene for vitamin K epoxide reductase. Nature 2004;427:541-544 (Pubitemid 38209111)
49. Tie JK, Nicchitta C, von Heijne G, Stafford DW. Membrane topology mapping of vitamin K epoxide reductase by in vitro translation/cotranslocation. J Biol Chem 2005;280:16410-16416 (Pubitemid 40616771)
50. Rost S, Fregin A, Hünerberg M, Bevans CG, Müller CR, Oldenburg J. Site-directed mutagenesis of coumarin-type anticoagulant-sensitive VKORC1: evidence that highly conserved amino acids define structural requirements for enzymatic activity and inhibition by warfarin. Thromb Haemost 2005;94:780-786 (Pubitemid 41489237)
51. Wajih N, Sane DC, Hutson SM, Wallin R. Engineering of a recombinant vitamin K-dependent gamma-carboxylation system with enhanced gamma-carboxyglutamic acid forming capacity: evidence for a functional CXXC redox center in the system. J Biol Chem 2005;280:10540-10547 (Pubitemid 40395914)
52. Preusch PC. Is thioredoxin the physiological vitamin K epoxide reducing agent? FEBS Lett 1992;305:257-259
53. Wajih N, Hutson SM, Wallin R. Disulfide-dependent protein folding is linked to operation of the vitamin K cycle in the endoplasmic reticulum. A protein disulfide isomerase-VKORC1 redox enzyme complex appears to be responsible for vitamin K1 2,3-epoxide reduction. J Biol Chem 2007; 282:2626-2635 (Pubitemid 47076752)
54. Myszka DG, Swenson RP. Synthesis of the photoaffinity probe 3-(p-azidobenzyl)-4-hydroxycoumarin and identification of the dicoumarol binding site in rat liver NAD(P)H:-quinone reductase (EC 1.6.99.2). J Biol Chem 1991;266:4789-4797
55. Ma Q, Cui K, Xiao F, Lu AY, Yang CS. Identification of a glycine-rich sequence as an NAD(P)H-binding site and tyrosine 128 as a dicumarol-binding site in rat liver NAD(P)H:quinone oxidoreductase by site-directed mutagenesis. J Biol Chem 1992;267:22298-22304
56. Jin DY, Tie JK, Stafford DW. The conversion of vitamin K epoxide to vitamin K quinone and vitamin K quinone to vitamin K hydroquinone uses the same active site cysteines. Biochemistry 2007;46:7279-7283
57. Chu PH, Huang TY, Williams J, Stafford DW. Purified vitamin K epoxide reductase alone is sufficient for conversion of vitamin K epoxide to vitamin K and vitamin K to vitamin KH2. Proc Natl Acad Sci U S A 2006;103:19308-19313 (Pubitemid 46026028)
58. Mousallem M, Spronk HM, Sacy R, Hakime N, Soute BA. Congenital combined deficiencies of all vitamin K-dependent coagulation factors. Thromb Haemost 2001;86:1334-1336 (Pubitemid 33064588)
59. McMahon MJ, James AH. Combined deficiency of factors II, VII, IX, and X (Borgschulte-Grigsby deficiency) in pregnancy. Obstet Gynecol 2001;97(5 Pt 2):808-809
60. Bolton-Maggs PH, Perry DJ, Chalmers EA, et al. The rare coagulation disorders - review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation. Haemophilia 2004;10:593-628
61. Köhler M. Thrombogenicity of prothrombin complex concentrates. Thromb Res 1999;95(4, Suppl 1):S13-S17